item management discussion and analysis of financial condition and results of operations 
results of operations versus non recurring and unusual charge 
the review of results that follows excludes the impact of the non recurring and unusual charge the charge taken in the reasons for the charge and the impact on the company s current and future performance is explained below under the heading non recurring and unusual charge later in this section 
net sales 
net sales for increased for the year net of a impact from foreign currency translation 
acquisitions contributed of the increase 
the net sales increase of  excluding acquisitions and the impact of foreign currency translation  was due to increased unit volumes as competitive pressures caused prices to decline for most product lines for the second consecutive year 
sales were also negatively impacted by due to reduced purchases by the company s largest customer 
despite the competitive pricing environment  almost all product lines had sales gains for the year 
custom wheelchairs power and custom manual  personal care products and standard wheelchairs posted the largest dollar increases 
the company believes that its sales growth was aided by its cost effective one stop shoppingsm distribution system that is supported by the company s broad range of products and services 
the company s goal is to increase sales by to per year with to internal growth and to growth through acquisition  although there can be no assurance that it will be able to achieve this goal 
north american operations rehab products group 
sales of the rehab products group  which consists of the power wheelchairs  custom manual wheelchairs and seating and positioning business units  increased for the year 
the gain was due principally to unit volume growth 
power wheelchairs continued to lead the way as sales for the power business unit increased resulting from continued strong volume growth in low end power chairs  scooter products and from the introduction of the new mid wheel drive power chairs 
sales of custom manual wheelchairs increased due to new product introductions and the continued success of the company s team action athletes  as many of the high tech design features in high performance sport wheelchairs are incorporated in the everyday action chairs 
the new action orbit tm tilt in space  a pediatric product  was introduced during and has gained widespread acceptance in the market 
unit growth exceeded the dollar increase due to pricing pressure in this product category 
standard products group 
sales of the standard products group  which consists of the manual wheelchairs patient transport  personal care  beds  low air loss therapy  invacare health care furnishings and retail business units  increased 
acquisitions contributed of the sales increase including two strategic acquisitions made during allied medical supply corporation acquired october  a distributor of soft goods and disposable products and silcraft corporation acquired may  a manufacturer of bathing equipment and patient lifts  contributed 
and respectively 
acquisitions made in that positively impacted sales growth include frohock stewart  a manufacturer of personal care products with distribution through mass retailers and invacare health care furnishings  a manufacturer and distributor of beds and furnishings for the non acute care markets 
the personal care product line posted a sales increase of over  while standard wheelchair sales increased modestly for the year 
sales of low air loss therapy products increased after showing significant decline in the prior year as changes in governmental reimbursements policies caused the overall market for those products to shrink dramatically from levels in the sales of this group also were impacted by the aforementioned reduction in purchases by a major customer in respiratory products group 
sales of the respiratory products group  which consists of the oxygen concentrator  liquid oxygen  aerosol therapy and associated respiratory products business units  decreased 
for the year 
volume increases were offset as significant pricing pressure continued in the products within this group  primarily oxygen concentrators  continue to experience the largest price decline of any of the company s product categories 
this product category was the area most effected by the reduction in purchases by the company s major customer 
other 
other products  consisting primarily of the company s canadian  australian and new zealand operations  aftermarket parts and ambulatory infusion pumps businesses  had a sales increase for the year  with due to acquisitions made in the prior year 
the company s canadian operation had another strong year with sales up  excluding a negative impact from foreign currency translation 
the company s new zealand operations  principally dynamic controls  was adversely affected by the sluggish european market for power wheelchairs  as their sales declined by excluding a negative impact for foreign currency translation 
european operations european sales increased  excluding a negative impact of from foreign currency translation 
acquisitions had a minimal impact on sales growth 
sales were significantly impacted by european governmental budget trends  especially in germany and france  that resulted in reduced reimbursement levels and caused providers to utilize more refurbished equipment 
gross profit 
gross profit as a percentage of net sales decreased to from last year 
the decline was a result of ongoing significant pricing pressures and a product mix shift  offset by continued productivity improvements and the cost reduction from strategic realignment of production facilities 
the company is committed to redesigning products to lower manufacturing costs while improving quality and reliability and implementing other spending reductions necessary to remain competitive and improve profitability 
north american gross profit from operations declined slightly despite an intensifying pricing environment 
continued manufacturing productivity improvements were somewhat offset by the impact of reduced purchases by a major customer in the facilities rationalization implemented during the year also favorably impacted the company s gross profit 
gross profit in europe declined to from in continued effects of a strong us dollar  overall price declines and product mix changes each negatively impacted margins 
a significant reduction in gross profit approximately million was the result of a failure to hedge certain transaction exposures early in inventory turns improved for in both the north american and european operations  as the plan for realignment of manufacturing facilities was initiated and implemented 
the company expects turns will continue to show improvement in as facility consolidations continue and strategic partnerships are formed with major suppliers 
selling  general and administrative 
selling  general and administrative expense as a percentage of net sales decreased to in compared to in the dollar decrease was  or  despite acquisitions which increased selling  general and administrative costs by approximately  or 
the businesses acquired operate with a significantly higher selling  general and administrative expense as a percentage of net sales however  tight expense control in the company s existing businesses resulted in a reduction in the overall expense as a percentage of sales for the company focuses on improved productivity and acquisition integration  which it expects can continue to favorably impact the selling  general and administrative expense as a percentage of net sales 
north american operations selling  general and administrative costs decreased as a percentage of net sales by approximately from last year  as the focus on expense control continued during the dollar change was minimal despite acquisitions which increased costs by approximately  in an effort to combat the competitive pricing environment  the company continued its implementation of activity based budgeting aimed at allocating the expense dollars to the programs that most effectively supported the company s business strategy 
the company s bad debt expense and reserve for bad debt substantially increased during the year due to expenses created by the balanced budget act and general competitive market 
the increase was taken as part of the non recurring and unusual charge 
there can be no assurance that future government actions or business conditions will not cause this to recur in the future 
european operations selling  general and administrative expenses  as a percentage of net sales  decreased to from in  with the dollar decrease amounting to  or 
acquisitions had a minimal impact on total costs 
the overall decrease is a result of restructuring and cost containment initiatives implemented throughout and the strong dollar which reduced selling  general and administrative expenses reported in dollars by interest 
interest income decreased in to  from  last year  representing a decrease 
the change between years was due primarily to the introduction of several new financing programs offered by the company s finance subsidiary 
these programs included a three and six month interest free financing period with rates at or below prime 
interest expense increased to  from  representing a increase resulting from additional borrowings incurred to fund the acquisitions and other investing activities  principally capital expenditures 
as a result  the company s debt to equity ratio increased to 
from 
it is anticipated that the company s interest expense will increase in as a result of the acquisition of suburban ostomy supply co  inc on january  income taxes 
the company had an effective tax rate of in  excluding the effects of the unusual and non recurring charge 
including the effects of the charge  the effective tax rate was compared to in as the impact of permanent differences increase or earnings decline 
see income taxes in the notes to consolidated financial statements for further discussion 
research and development 
the company continues to increase its research and development activities to maintain its competitive advantage 
while the competitive environment requires that research and development expenditures be focused on the cost reduction of products while increasing functionality and reliability  the company continues to dedicate dollars to applied research activities to ensure that new and enhanced design concepts are available to its businesses 
research and development expenditures increased to  from  in the expenditures  as a percentage of sales  increased only slightly because businesses acquired spent less on research and development as a percent of sales than the company 
versus net sales 
net sales for increased for the year with the net effect of acquisitions and currency translation accounting for of the increase 
the sales increase of  excluding acquisitions and the impact of foreign currency translation  was due to increased unit volumes as competitive pressures caused prices to decline for most product lines again in all product lines  with the exception of therapeutic support surfaces  liquid and dynamic control had sales gains for the year with personal care products  custom wheelchairs power and custom manual  standard wheelchairs and concentrators posting the largest dollar and percentage increases 
the company believes its sales growth was aided by its cost effective one stop shoppingsm distribution system that is supported by the company s broad range of products and services 
the company sales goals are to increase sales at a level that is greater than the overall market growth rate and to reach billion in sales by the year north american operations rehab products group 
sales of the rehab products group  which consists of the power wheelchairs  custom manual wheelchairs and seating and positioning business units  increased for the year  with of the increase due to the acquisitions of pindot products in mid and special health systems in late the gain was due principally to unit volume growth although prices for certain product lines were increased slightly during the year 
power wheelchairs continued to lead the way as sales for the power business unit increased with over of the improvement coming from increased unit sales 
sales of custom manual wheelchairs also showed double digit growth as the success of the company s team action athletes in the atlanta paralympic games helped to enhance sales of our everyday action chairs that incorporate many of the high tech design features and materials used in the high performance sports wheelchairs 
seating and positioning sales increased principally as a result of the acquisitions made to complete this product line in excluding acquisitions  sales of seating and positioning products achieved double digit levels in units  however the increase in dollars was limited to due to the pricing pressures experienced during the year 
standard products group 
sales of the standard products group  which consists of the manual wheelchairs patient transport  personal care  beds  low air loss therapy and invacare continuing care group business units  increased 
the acquisition of invacare continuing care group  a manufacturer and distributor of beds and furnishings for the extended and acute care markets  contributed approximately to the increase 
the group s unit volume increase was greater than the reported dollar increase  as again in the product lines within this group experienced significant competitive pricing pressure 
the personal care product line posted a sales increase of over  while standard wheelchairs sales increased for the year 
sales of low air loss therapy products declined significantly for the year as changes in governmental reimbursements policies caused the overall market for those products to shrink dramatically from respiratory products group 
sales of the respiratory products group  which consists of the oxygen concentrator  liquid oxygen  aerosol therapy and associated respiratory products business units  increased for the year 
volume increases were significantly greater than the overall sales dollar increase as significant pricing pressure continued in the products within the group  primarily oxygen concentrators  experienced the largest price decline of any of the company s product categories 
the company still managed to increase its market share position to become the leader in oxygen concentrators during  as sales to both national accounts and independent providers increased at a rate greater than the overall market growth rate 
other 
other  consisting primarily of the company s canadian  new zealand and australian operations  retail  aftermarket parts business and ambulatory infusion pumps  had a sales increase for the year  with almost all of the increase due to acquisitions 
the company s canadian operation had another strong year with sales up  including a 
positive impact from foreign currency translation 
this gain was offset by a down year in sales at dynamic controls  the company s electronic wheelchair controller business  due primarily to the loss of a large customer during who is also a major competitor to the company 
the acquisitions made in that positively impacted sales growth include frohock stewart  a manufacturer of personal care products with distribution through mass retailers  production research company  a supplier of aftermarket parts for the home medical equipment market and rollerchair pty 
ltd  a manufacturer and distributor of custom power wheelchairs in australia 
european operations european sales increased  with acquisitions accounting for of the increase 
foreign currency translation had a negative effect on the reported sales of 
sales increased in almost all product lines  with power wheelchairs and patient aid sales posting the largest dollar increases 
competitive pricing pressure intensified in europe in  resulting in higher unit volume growth than the reported increase in dollars 
the european sales growth was enhanced by a significant percentage increase in the sales of beds and respiratory products 
the absolute level of sales for these products is still relatively small as they represent new product categories in the european market 
the introduction of these product lines support the company s goal of mirroring the product lines of our north american operations in europe 
gross profit 
gross profit as a percentage of net sales decreased to from last year  due primarily to businesses acquired which had lower gross margins than the company s existing businesses 
despite ongoing intense price competition  excluding businesses acquired  gross margins were basically flat with last year 
the company s continued focus on cost reductions in all of its business processes was the principal reason margins were held level in the ongoing competitive environment 
the company intends to continue to focus on improving productivity  redesigning products to lower manufacturing costs while improving quality and reliability and implement other spending reductions to remain competitive 
the company is continuing its initiative of realigning production among locations and consolidating certain facilities in order to achieve improved productivity  efficiency and reduction of costs 
north american operations gross profit  excluding businesses acquired  increased from last year as a result of improved manufacturing productivity  reduced distribution costs and improved purchasing synergies which were only partially affected by the negative effects of the competitive pricing environment and a shift in product mix 
gross profit in europe declined significantly to from in the decline was due in part to increased pricing competition in europe but was primarily the result of internal operating difficulties 
poor implementation of the manufacturing and purchasing improvement plans for the year as well as a lack of control over freight and distribution costs were the major factors contributing to the decline 
the company believes that it has plans in place so that these problems do not reoccur in inventory turns declined in in both the north american and european operations  negatively impacting gross margins for the year 
the company expects that turns will improve in as the realignment of manufacturing facilities is implemented 
as stated above  the company believes its focus on reducing costs in all of its business processes and improving productivity will enhance for future competitiveness and profitability 
selling  general and administrative 
selling  general and administrative expense as a percentage of net sales was in compared to in the dollar increase was  or 
acquisitions increased selling  general and administrative costs by approximately  for the year  representing approximately of the percentage increase 
the businesses acquired operate with a significantly higher selling  general and administrative expense as a percent of sales ratio  however  tight expense control in the company s existing businesses resulted in a reduction in the overall percentage of sales ratio in it is expected that the ratio for the company as well as the acquired businesses will decline in the future as the company focuses on improved productivity and activity based management 
north american operations selling  general and administrative costs increased as a percent of sales by approximately from last year 
excluding acquisitions  these costs were lower than last year as the focus on continued expense control intensified during as a result of the competitive pricing environment 
the company also refocused its efforts on activity based budgeting during the year to ensure that the expense dollars spent were allocated to the programs that most effectively supported the company s business strategy 
the company made substantial investments in  primarily related to brand strategy and clinical application specialists  that it believes had a positive impact on growth in and will also favorably impact growth opportunities in the future 
european operations selling  general and administrative expenses  as a percentage of sales  increased to from in  with the dollar increase amounting to  or 
acquisitions accounted for over one half of the dollar increase 
the balance of the increase was a result of spending required to build the infrastructure needed to implement a full line product strategy in europe which began during  resulting in increased spending of for the year  excluding acquisition impact 
the company believes the infrastructure investments in europe will provide the organizational structure required to support future growth as well as a full line product strategy 
interest 
interest income in increased to  from  last year  a increase  due primarily to increased financing activity by the company s finance subsidiary that resulted in higher average outstanding installment loans 
interest expense increased to  or  primarily as a result of the additional borrowings incurred to fund the acquisition and other investing activity 
the company s debt to equity ratio increased marginally to 
from 
it is anticipated that the company s interest expense  in the absence of additional acquisitions or significant increases in borrowing rates  will decline due to the company s strong cash flows from operations offset to some extent by additional capital expenditures planned for income taxes 
the company had an effective tax rate of in compared to in see income taxes in the notes to consolidated financial statements for further discussion 
research and development 
the company continues to increase its research and development activities to maintain its competitive advantage 
while the competitive environment requires that research and development expenditures be focused on the cost reduction of products while increasing functionality and reliability  the company continues to dedicate dollars to applied research activities to ensure that new and enhanced design concepts are available to its businesses 
research and development expenditures increased to  from  in the expenditures  as a percent of sales  remained at as businesses acquired spent less on research and development as a percent of sales than the company 
for certain of the acquired businesses  future spending is anticipated to be more in line with the company s overall spending levels 
inflation although the company cannot determine the precise effects of inflation  management believes that inflation does continue to have an influence on the cost of materials  salaries and benefits  utilities and outside services 
the company attempts to minimize or offset the effects through increased sales volume  capital expenditure programs designed to improve productivity  alternative sourcing of material and other cost control measures 
in and  the company was able to offset the majority of the impact of price increases from suppliers by productivity improvements and other cost reduction activities 
liquidity and capital resources the company continues to maintain an adequate liquidity position through its unused bank lines of credit see long term obligations in the notes to consolidated financial statements and working capital management 
the company maintains various bank lines of credit to finance its worldwide operations 
in  the company completed a  multi currency  long term revolving credit agreement which expires on october   or such later date as mutually agreed upon by the company and the banks 
additionally  the company maintains various other demand lines of credit totaling a us dollar equivalent of approximately  as of december  the lines of credit have been and will continue to be used to fund the company s domestic and foreign working capital  capital expenditures and acquisition requirements 
as of december   the company had approximately  available under its various lines of credit 
subsequent to year end  the company completed a private placement of  in senior notes having a blended fixed coupon rate of with  maturing in seven years and  maturing in ten years 
the proceeds were used to pay down revolving credit debt incurred to fund the acquisition of suburban ostomy supply co  inc  which was consummated on january  the company s borrowing arrangements contain covenants with respect to net worth  dividend payments  working capital  funded debt to capitalization and interest coverage  as defined in the company s bank agreements and agreement with its note holders 
the company is in compliance with all covenant requirements 
under the most restrictive covenant of the company s borrowing arrangements  the company may borrow up to an additional  as of december  capital expenditures there are no individually material capital expenditure commitments outstanding as of december  however  the company expects to invest approximately  in capital projects in the decrease in capital spending in is due principally to the expansion of three manufacturing facilities  the completion of a new respiratory manufacturing plant and the completion of a new corporate headquarters building in the company believes that its balances of cash and cash equivalents  together with funds generated from operations and existing borrowing capabilities  will be sufficient to meets its operating cash requirements and fund required capital expenditures in the foreseeable future 
cash flows cash flows provided by operating activities were  compared to  last year 
the increase is primarily the result of decreased inventory levels from the prior year  as continued focus on inventory management initiatives have proven effective  and an increase in accrued expenses relating to the unpaid portion of the unusual charge taken in the improved cash flow was offset to some extent by an increase in trade receivables 
the changes in operating assets and liabilities are not apparent from the face of the balance sheet as funds expensed for assets acquired through business acquisitions are accounted for in the investment activities section of the consolidated statement of cash flows 
cash flows required for investing activities decreased by  or 
the decrease was a result of reduced acquisition activity in and the sale of the company s investment in healthdyne technologies  inc 
the decrease was offset by an increase in capital expenditures primarily relating to investments in computer systems  production machinery and equipment and facility expansions associated with the continuing implementation of a worldwide facilities plan 
cash flows provided by financing activities were  in compared to  in the decrease in cash provided by financing activities was primarily a result of a reduction in net proceeds from long term borrowings which were used to fund acquisitions in the prior year and increased payments on revolving lines of credit when compared to the prior year 
in addition to acquisition activities  the effect of foreign currency translation results in amounts being shown for cash flows in the consolidated statement of cash flows that are different from the changes reflected in the respective balance sheet captions 
dividend policy it is the company s policy to pay a nominal dividend in order for its stock to be more attractive to a broader range of investors 
the current annual dividend rate remains at 
per common share and 
per class b common share 
it is not anticipated that this will change materially as the company continues to have available significant growth opportunities through internal development and acquisitions 
for  a dividend of 
per common share and 
per class b common share were declared and paid 
year issue the year issue is the result of computer programs being written using the last two digits rather than four to define the applicable year 
thus  many programs are unable to properly distinguish between the year and the year this is frequently referred to as the year problem 
the company has developed a plan to modify its existing information technology in order to recognize the year and has begun converting its critical data processing systems 
the plan is designed to ensure that there is no adverse effect on the company s core business operations and that transactions with customers  suppliers and financial institutions are fully supported 
the company is well under way with these efforts and believes its planning and implementation efforts will be adequate to address its year concerns 
currently  the project is expected to be substantially completed by early and to cost between and million 
this estimate includes internal costs and excludes the costs to upgrade and replace systems in the normal course of business 
the company does not expect this project to have a significant effect on the company s results of operations or financial position 
for the year ended december   approximately  was incurred and expensed related to this activity 
the company will continue to implement systems with strategic long term value as it has undertaken a long term systems improvement program that will result in a global enterprise resource planning erp system utilizing certain of the oracle erp product modules 
while the review of the project has been revised from the original plan  the company still plans to spend significant funds over the next several years implementing its new systems plan 
this program is expected to cost approximately million over the next four years including internal costs 
non recurring and unusual charge in  the company recorded a non recurring and unusual charge of   or diluted per share after tax for the acceleration of certain strategic initiatives and other items 
the charge impacted cost of products sold by approximately  and selling  general and administrative expenses by approximately  during the fourth quarter  the company reviewed the charge and its related estimates and components 
the review resulted in certain changes to the components of the charge 
in addition  while reviewing the technical requirements of financial accounting standards board fasb emerging issues task force eitf and all relevant accounting pronouncements  it was determined that part of the charge related to the fourth quarter rather than the third quarter and the company restated the quarters to reflect this change 
there was no significant impact on results recorded for the year 
the charge includes  for the acceleration of global manufacturing facility consolidations and the elimination of certain non strategic product lines   for certain accelerated global systems initiatives   for an increase in the company s bad debt reserve and  for asset write downs and an increase in reserves for litigation 
the portion of the charge identified for certain global systems initiatives relates to the write off of assets that will not benefit future periods due to new systems replacements or the change in scope of the original project 
there were no year costs charged to the reserve as these costs are expensed as incurred pursuant to the requirements of the financial accounting standards board fasb emerging issues task force eitf the company initiatives included in the charge are anticipated to be substantially completed in during  approximately  of the reserve amount was utilized for facility consolidations and business exits   for systems related costs   for the write off of specifically identified accounts receivable and an increase in the general reserve for bad debts and  for asset write downs and litigation 
the remaining accrual balance at december  in the amount of  relates primarily to facility consolidations  business exits  litigation and bad debt 
private securities litigation reform act this management s discussion contains forward looking statements based on current expectations which are covered under the safe harbor provision within the private securities litigation reform act of actual results and events  including the acceleration of certain strategic initiatives for which a non recurring and unusual charge has been reported  may differ significantly from those anticipated as a result of risks and uncertainties which include  but are not limited to  pricing pressures  the consolidations of health care customers and competitors  the availability of strategic acquisition candidates successfully completing its project to resolve its year issues and invacare s ability to effectively integrate acquired companies  the timely completion of facility consolidations and other strategic initiatives provided for  the completion of year compliance programs and the overall economic  market and industry conditions  as well as the risks described from time to time in invacare s reports as filed with the securities and exchange commission 

